Dr. Deepak L. Bhatt, MD
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Years since graduation
- 33
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 11
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
NY license 319873 · RI license MD16374 -
Cardiovascular Disease Physician
MA license 237177
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Mount Sinai Hospital New York, NY
Medical groups
- Icahn School of Medicine at Mount Sinai (2,843 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 11
- Services billed
- 44
- Patients’ average age
- 78
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 16 companies reported 106 payments worth $540,549 in total to this clinician.
| Bristol Myers Squibb Company | $422,899 |
|---|---|
| Boston Scientific Corporation | $57,420 |
| Sanofi US Services Inc. | $20,109 |
| Btg International Inc. | $16,200 |
| GlaxoSmithKline, LLC. | $9,400 |
| Corcept Therapeutics | $5,100 |
| Boehringer Ingelheim International GmbH | $3,180 |
| Atricure, Inc. | $2,500 |
| Compensation for services other than consulting (speaking, faculty) | $361,829 |
|---|---|
| Consulting Fee | $102,831 |
| Travel and Lodging | $66,502 |
| Food and Beverage | $6,226 |
| Honoraria | $2,085 |
| Education | $1,078 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Bristol Myers Squibb Company Feb 1, 2025 | Compensation for services other than consulting (speaking, faculty) stock | $210,000 |
| Bristol Myers Squibb Company Dec 26, 2025 | Compensation for services other than consulting (speaking, faculty) | $35,000 |
| Bristol Myers Squibb Company Mar 21, 2025 | Compensation for services other than consulting (speaking, faculty) | $35,000 |
| Bristol Myers Squibb Company Jun 26, 2025 | Compensation for services other than consulting (speaking, faculty) | $35,000 |
| Bristol Myers Squibb Company Sep 25, 2025 | Compensation for services other than consulting (speaking, faculty) | $35,000 |
| Boston Scientific Corporation Dec 18, 2025 | Consulting Fee Clinical Trial Product · Clinical Trial Product_PI | $31,320 |
| Boston Scientific Corporation Dec 4, 2025 | Consulting Fee Clinical Trial Product · Clinical Trial Product_PI | $26,100 |
| Bristol Myers Squibb Company Sep 15, 2025 | Travel and Lodging travel to San Diego, CA · in-kind | $23,314 |
| Btg International Inc. Sep 11, 2025 | Consulting Fee | $16,200 |
| Bristol Myers Squibb Company Sep 17, 2025 | Travel and Lodging travel to San Diego, CA · in-kind | $11,428 |
All 50 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Bristol Myers Squibb Company Dec 26, 2025 | Compensation for services other than consulting (speaking, faculty) | $35,000 |
| Boston Scientific Corporation Dec 18, 2025 | Consulting Fee Clinical Trial Product · Clinical Trial Product_PI | $31,320 |
| Sanofi US Services Inc. Dec 15, 2025 | Consulting Fee | $4,892 |
| Bristol Myers Squibb Company Dec 10, 2025 | Travel and Lodging travel to New York, NY · in-kind | $1,092 |
| Bristol Myers Squibb Company Dec 9, 2025 | Travel and Lodging travel to New York, NY · in-kind | $424 |
| Bristol Myers Squibb Company Dec 9, 2025 | Travel and Lodging travel to New York, NY · in-kind | $378 |
| Bristol Myers Squibb Company Dec 8, 2025 | Travel and Lodging travel to New York, NY · in-kind | $739 |
| Bristol Myers Squibb Company Dec 8, 2025 | Travel and Lodging travel to New York, NY · in-kind | $284 |
| Boston Scientific Corporation Dec 4, 2025 | Consulting Fee Clinical Trial Product · Clinical Trial Product_PI | $26,100 |
| Sanofi US Services Inc. Nov 17, 2025 | Consulting Fee | $9,239 |
| Atricure, Inc. Nov 14, 2025 | Consulting Fee | $750 |
| Atricure, Inc. Nov 14, 2025 | Consulting Fee | $750 |
| Atricure, Inc. Nov 14, 2025 | Consulting Fee | $500 |
| Boehringer Ingelheim International GmbH Nov 4, 2025 | Consulting Fee | $3,180 |
| Atricure, Inc. Oct 3, 2025 | Consulting Fee | $500 |
| Alnylam Pharmaceuticals Inc. Oct 3, 2025 | Travel and Lodging travel to Boston, MA · in-kind | $408 |
| Bristol Myers Squibb Company Sep 25, 2025 | Compensation for services other than consulting (speaking, faculty) | $35,000 |
| GlaxoSmithKline, LLC. Sep 23, 2025 | Consulting Fee | $800 |
| Bristol Myers Squibb Company Sep 17, 2025 | Travel and Lodging travel to San Diego, CA · in-kind | $11,428 |
| Bristol Myers Squibb Company Sep 17, 2025 | Travel and Lodging travel to San Diego, CA · in-kind | $503 |
| Sanofi-aventis U.S. LLC Sep 17, 2025 | Compensation for services other than consulting (speaking, faculty) PRALUENT · Cardiology/Vascular Diseases · in-kind Company’s descriptionIf more than one clinical reprint is received on the same day, the reported transfer of value will reflect the aggregate total. | $500 |
| Sanofi-aventis U.S. LLC Sep 17, 2025 | Compensation for services other than consulting (speaking, faculty) PRALUENT · Cardiology/Vascular Diseases · in-kind Company’s descriptionIf more than one clinical reprint is received on the same day, the reported transfer of value will reflect the aggregate total. | $250 |
| Bristol Myers Squibb Company Sep 15, 2025 | Travel and Lodging travel to San Diego, CA · in-kind | $23,314 |
| Bristol Myers Squibb Company Sep 15, 2025 | Travel and Lodging travel to San Diego, CA · in-kind | $1,390 |
| Bristol Myers Squibb Company Sep 15, 2025 | Travel and Lodging travel to San Diego, CA · in-kind | $379 |
| Bristol Myers Squibb Company Sep 15, 2025 | Travel and Lodging travel to San Diego, CA · in-kind | $322 |
| Btg International Inc. Sep 11, 2025 | Consulting Fee | $16,200 |
| GlaxoSmithKline, LLC. Sep 9, 2025 | Consulting Fee | $6,000 |
| Philips North America LLC Sep 3, 2025 | Honoraria | $2,085 |
| Corcept Therapeutics Jul 23, 2025 | Compensation for services other than consulting (speaking, faculty) Korlym · Endocrinology | $5,100 |
| Sanofi US Services Inc. Jul 1, 2025 | Compensation for services other than consulting (speaking, faculty) | $5,979 |
| Bristol Myers Squibb Company Jun 26, 2025 | Compensation for services other than consulting (speaking, faculty) | $35,000 |
| Bristol Myers Squibb Company Jun 20, 2025 | Travel and Lodging travel to Rome, Italy · in-kind | $418 |
| Bristol Myers Squibb Company Jun 16, 2025 | Travel and Lodging travel to Rome, Italy · in-kind | $9,071 |
| Bristol Myers Squibb Company Jun 16, 2025 | Travel and Lodging travel to Rome, Italy · in-kind | $856 |
| Bristol Myers Squibb Company Jun 15, 2025 | Travel and Lodging travel to Rome, Italy · in-kind | $6,397 |
| Bristol Myers Squibb Company Jun 15, 2025 | Travel and Lodging travel to Rome, Italy · in-kind | $4,125 |
| Bristol Myers Squibb Company Jun 15, 2025 | Travel and Lodging travel to Rome, Italy · in-kind | $255 |
| GlaxoSmithKline, LLC. Jun 3, 2025 | Consulting Fee | $400 |
| Bristol Myers Squibb Company May 6, 2025 | Travel and Lodging travel to Princeton, NJ · in-kind | $1,447 |
| Bristol Myers Squibb Company May 5, 2025 | Travel and Lodging travel to Princeton, NJ · in-kind | $1,451 |
| Bristol Myers Squibb Company Mar 21, 2025 | Compensation for services other than consulting (speaking, faculty) | $35,000 |
| GlaxoSmithKline, LLC. Mar 20, 2025 | Consulting Fee | $600 |
| Merck Sharp & Dohme LLC Mar 14, 2025 | Education in-kind | $25.70 |
| Bristol Myers Squibb Company Mar 13, 2025 | Education in-kind | $1,052 |
| GlaxoSmithKline, LLC. Mar 4, 2025 | Consulting Fee | $800 |
| Bristol Myers Squibb Company Feb 12, 2025 | Travel and Lodging travel to Summit, NJ · in-kind | $999 |
| Bristol Myers Squibb Company Feb 11, 2025 | Travel and Lodging travel to Summit, NJ · in-kind | $822 |
| Bristol Myers Squibb Company Feb 1, 2025 | Compensation for services other than consulting (speaking, faculty) stock | $210,000 |
| GlaxoSmithKline, LLC. Jan 10, 2025 | Consulting Fee | $800 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 4 industry-funded studies in 2025, from 3 companies. The companies reported $873,401 in research payments for these studies, mostly to the institutions running them.
- REDUCE-IT
Amarin Pharma, Inc. - TRANSFORM
Cleerly, Inc. - Study name not reported
Novartis Pharma AG - CKJX839B12302
Novartis Pharma AG
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.